About Avadel Pharmaceuticals Plc
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.
At the moment the company generates 48M USD in revenues.
On its last earning announcement, the company reported a profit of 0.27$ per share.
The book value per share is -0.72$
Create a solid portfolio with AVDL
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|